Spectral CT With Advanced CT Technology

General Electric (GE)

Status: Completed

Conditions: CT Photon-Counting

Treatments: Device: CT with a photon-counting detector

Study type: Interventional

Funder types: Industry; Other

Identifiers

NCT04781296

20201218-01

Details and patient eligibility

About

The purpose of the study is to collect data to evaluate feasibility of the using photon-counting CT in a clinical setting.

Full description

Data collected in this study includes an assessment of image quality parameters including spatial resolution, image contrast, and noise that will evaluate the product and how this photon-counting CT technology can be used to reduce the overall radiation dose in CT imaging, and enhance clinical applications for CT technology.

Enrollment: 30 patients

Sex: Male

Ages: 50+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age >50 years
• Male
• Normal renal function per standardized guidelines (GFR > 60 mL/min)
• Previous CT examination at KS no more than 12 months prior to the study examination
• Signed informed consent

Exclusion criteria

• Iodine contrast is contraindicated.

Trial design

Primary purpose: Device Feasibility

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

30 participants in 1 patient group

Subject's Scanned with Investigational Device

Experimental group

Treatment:

Device: CT with a photon-counting detector